Journals / Turkish Journal of Gastroenterology / 2018 / Cilt: 29 - Sayı: 2

Myotonic dystrophy type 1 and pseudo-obstruction in a child with smooth muscle α-actin deficiency and eosinophilic myenteric plexitis

Pages
226–229
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this peculiar case, the clinical aspects of CIPO might have been due to the involvement of several neuromuscular mechanisms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myotonic dystrophy (MD) frequently involves the gastrointestinal tract, where it can manifest as chronic intestinal pseudo-obstruction (CIPO), particularly in adults.
📊
Key Findings & Data:We report the case of a 12-year-old boy with MD type 1 and CIPO, in which a pathologic assessment revealed an association with smooth muscle α-actin deficiency in the external muscular layer of the ileum, and with features of eosinophilic plexitis and eosinophilic muscle infiltration in the colon.
💡
Conclusion & Impact:In this peculiar case, the clinical aspects of CIPO might have been due to the involvement of several neuromuscular mechanisms.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Myotonic dystrophy (MD) frequently involves the gastrointestinal tract, where it can manifest as chronic intestinal pseudo-obstruction (CIPO), particularly in adults. This manifestation is quite uncommon in children. We report the case of a 12-year-old boy with MD type 1 and CIPO, in which a pathologic assessment revealed an association with smooth muscle α-actin deficiency in the external muscular layer of the ileum, and with features of eosinophilic plexitis and eosinophilic muscle infiltration in the colon. In this peculiar case, the clinical aspects of CIPO might have been due to the involvement of several neuromuscular mechanisms.

🔖

Cite This Article

PELİZZO, G., CALCATERRA, V., VILLANACCI, V., MURA, G. B., BASSOTTI, G. (2018). Myotonic dystrophy type 1 and pseudo-obstruction in a child with smooth muscle α-actin deficiency and eosinophilic myenteric plexitis. Turkish Journal of Gastroenterology, Cilt: 29 - Sayı: 2, 226–229. https://ajindex.com/articles/410149

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Lowichik A, Weinberg AG. Eosinophilic infiltration of the enteric neural plexuses in Hirschsprung’s disease. Pediatr Pathol Lab Med 1997; 17: 885-91. [CrossRef] 10. de Betue CT, Boersma D, Oomen MW, Benninga MA, de Jong JR. Volvulus as a complication of chronic intestinal pseudo-obstruction syndrome. Eur J Pediatr 2011; 170: 1591-5. [CrossRef] 9. Schappi MG, Smith VV, Milla PJ, Lindley KJ. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut 2003; 52: 752-5. [CrossRef] 8. Knowles CH, Silk DB, Darzi A, et al. Deranged smooth muscle al-pha-actin as a biomarker of intestinal pseudo-obstruction: a con-trolled multinational case series. Gut 2004; 53: 1583-9. [CrossRef] 7. Gamba E, Carr NJ, Bateman AC. Deficient alpha smooth muscle actin expression as a cause of intestinal pseudo-obstruction: fact or fiction? J Clin Pathol 2004; 57: 1168-71. [CrossRef] 6. Yoshida MM, Krishnamurthy S, Wattchow DA, Furness JB, Schuf-fler MD. Megacolon in myotonic dystrophy caused by a degenera-tive neuropathy of the myenteric plexus. Gastroenterology 1988; 95: 820-7. [CrossRef] 5. Nowak TV, Ionasescu V, Anuras S. Gastrointestinal manifestations of the muscular dystrophies. Gastroenterology 1982; 82: 800-10. 4. Bassotti G, Villanacci V, Sidoni A, et al. Myenteric plexitis: A fre-quent feature in patients undergoing surgery for colonic diverticular disease. United European Gastroenterol J 2015; 3: 523-8. [CrossRef] 3. Di Nardo G, Di Lorenzo C, Lauro A, et al. Chronic intestinal pseu-do-obstruction in children and adults: diagnosis and therapeutic op-tions. Neurogastroenterol Motil 2017; 29: e12945. [CrossRef] 2. Bellini M, Biagi S, Stasi C, et al. Gastrointestinal manifestations in myotonic muscular dystrophy. World J Gastroenterol 2006; 12: 1821-8 1. De Antonio M, Dogan C, Hamroun D, et al. Unravelling the myoton-ic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification. Rev Neurol (Paris) 2016; 172: 572-80. [CrossRef]